Replies to post #101856 on Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

Last week below a dime.

If you don't think that the share price could hit .50 with a LymPro partnership and two or three well placed news items then you haven't followed many penny stocks. 99% of them didn't have anything close to the "legitimate" potential that Amarantus offers both short and long term.

Stay on the sidelines waiting for a pullback and you'll miss the opportunity to "buy at the bottom". 99% of the individuals that will own AMBS shares in two years still haven't heard of LymPro or MANF.

Interesting weeks ahead.

Twitter: @AmarantusBio .... 9,970 followers